Heightened ceramide metabolism via, for example, the enhanced levels of sphingosine kinases, acid ceramidase or glucosylceramide synthase, commonly observed in many cancers, may clear this elevated ceramide and overcome radio/chemotherapy-induced cell death, providing a mechanism for cancer resistance to these therapies [129,130,131,136]. The gene discussed is UGCG; the disease is cancer.